Filing Details

Accession Number:
0001140361-15-002627
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-01-23 21:45:12
Reporting Period:
2015-01-21
Filing Date:
2015-01-23
Accepted Time:
2015-01-23 21:45:12
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1416792 Relypsa Inc RLYP Pharmaceutical Preparations (2834) 260893742
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1591469 A. Ronald Krasnow C/O Relypsa, Inc.
700 Saginaw Drive
Redwood City CA 94063
See Remarks No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2015-01-21 8,081 $2.76 33,929 No 4 M Direct
Common Stock Acquisiton 2015-01-21 33,368 $3.96 67,297 No 4 M Direct
Common Stock Acquisiton 2015-01-21 13,551 $3.96 80,848 No 4 M Direct
Common Stock Disposition 2015-01-21 55,000 $35.00 25,848 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 M Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock Stock Option (right to buy) Disposition 2015-01-21 8,081 $0.00 8,081 $2.76
Common Stock Stock Option (right to buy) Disposition 2015-01-21 33,368 $0.00 33,368 $3.96
Common Stock Stock Option (right to buy) Disposition 2015-01-21 13,551 $0.00 13,551 $3.96
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2019-03-10 No 4 M Direct
8,783 2021-09-13 No 4 M Direct
37,611 2022-09-27 No 4 M Direct
Footnotes
  1. Includes 5,500 restricted stock units.
  2. The sales reported in this Form 4 were effected pursuant to the Reporting Person's Rule 10b5-1 trading plan.
  3. 100% of the shares subject to the option are fully vested and exercisable.
  4. The shares subject to the option are early exercisable. 1/48th of the shares subject to the option vest on each monthly anniversary measured from September 1, 2011 (the "Vesting Commencement Date"), such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.
  5. The shares subject to the option are early exercisable. 25% of the shares subject to the option vest on the first anniversary measured from September 19, 2012 (the "Vesting Commencement Date"), and 1/48th of the total number of shares vest in thirty-six (36) successive and equal monthly installments thereafter, such that 100% of the shares subject to the option will be fully vested on the fourth anniversary of the Vesting Commencement Date.